Exagen Inc (NAS:XGN)
$ 2.75 -0.04 (-1.43%) Market Cap: 47.81 Mil Enterprise Value: 47.91 Mil PE Ratio: 0 PB Ratio: 2.72 GF Score: 70/100

Q3 2020 Exagen Inc Earnings Call Transcript

Nov 10, 2020 / 09:30PM GMT
Release Date Price: $16.05 (+3.22%)
Operator

Good afternoon, and welcome to the Exagen Inc. Third Quarter 2020 Earnings Call. (Operator Instruction] As a reminder, this conference is being recorded.

I would now like to turn the conference over to your host, Mr. Mike Cavanaugh, Investor Relations. Thank you. You may begin.

Mike Cavanaugh

Good afternoon, and thank you for joining us today. Earlier today, Exogen Inc. released financial results for the quarter ended September 30, 2020. The release is currently available on the company's website at www.exogen.com. Ron Rocca, President and Chief Executive Officer; Kamal Adawi, Chief Financial Officer; and Mark Hazeltine, General Manager, will host this afternoon's call.

Before we get started, I would like to remind everyone that management will be making statements during this call that include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot